Home / Levodopa and Decarboxylase Inhibitor / Sweden
SE ATC N04BA02 · updated 2 Nov 2026
Levodopa and Decarboxylase Inhibitor shortage in Sweden
Is there a Levodopa and Decarboxylase Inhibitor shortage in Sweden?
Yes. As of 2 Nov 2026, 1 Levodopa and Decarboxylase Inhibitor product is reported short in Sweden, the first since 1 May 2026. The company estimate for the return is 30 Jun 2027. Main reason: not stated.
Also short in Canada, Czechia, Norway. All countries.
Affected products in Sweden
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Carbidopa/Levodopa Orifarm 25 mg/100 mg Blister, 100 tabletter | Orifarm Healthcare A/S | 1 May 2026 | 30 Jun 2027 | Not stated |
Source
Läkemedelsverket (Swedish Medical Products Agency). Official list. Ongoing and announced shortages (restanmälningar) reported by companies; one row per pack.